Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Patrick O. Bolan"'
Autor:
Steven T. K. Hill, Rafael C. Schulman, Margaret K. Callahan, Patrick O. Bolan, Gavin Ha, Nicolas Robine, Sunil Deochand, Chelston Ang, Brian Houck-Loomis, Adam J. Widman, Asaf Zviran, Catherine F. Spinelli, Christian Stolte, Viktor A. Adalsteinsson, Alexi M. Runnels, Giorgio Inghirami, Sarah C. Reed, Federico Gaiti, Benchun Miao, Jedd D. Wolchok, Cole C. Khamnei, Nasser K. Altorki, Samantha Fennessey, Murtaza Malbari, Genevieve M. Boland, Will Liao, Dillon Maloney, Jennifer Ishii, Tatyana Sharova, Kevin Y. Huang, Kristofer Patel, Tommy Kim, Nathaniel D. Omans, Denisse Rotem, Dan A. Landau, Andrew Lipsky, Justin Rhoades, Selena Kazancioglu, Greg Gydush, Minita Shah, Phillip Wong, Dennie T. Frederick
Publikováno v:
Nat Med
In many areas of oncology, we lack sensitive tools to track low-burden disease. Although cell-free DNA (cfDNA) shows promise in detecting cancer mutations, we found that the combination of low tumor fraction (TF) and limited number of DNA fragments r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a39e84c85ee6c6a61dd9d8a91de2d20
https://europepmc.org/articles/PMC8108131/
https://europepmc.org/articles/PMC8108131/
Autor:
Patrick O. Bolan, Federica Piccioni, Cory M. Johannessen, Neville Dusaj, Lisa Brenan, Asaf Zviran, Amy Goodale, Joshua S. Schiffman, Dan A. Landau
Publikováno v:
Cell Syst
Summary Cancer evolution poses a central obstacle to cure, as resistant clones expand under therapeutic selection pressures. Genome sequencing of relapsed disease can nominate genomic alterations conferring resistance but sample collection lags behin
Autor:
Viktor A. Adalsteinsson, Cory M. Johannessen, Patrick O. Bolan, Lisa Brenan, Asaf Zviran, Denisse Rotem, Federica Piccioni, Amy Goodale, Dan A. Landau
Publikováno v:
Cancer Research. 78:1178-1178
Targeted EGFR inhibition in lung cancer leads to dramatic responses. Nonetheless, disease evolution to resistance is the rule. As this evolutionary process is fueled by intra-tumoral genetic diversity, a comprehensive mapping of clonal fitness is req